Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 6 of the 13 calendar months from Oct 2025 to Oct 2026: Dec 2025, Mar 2026, May 2026, Jun 2026, Aug 2026 and Sep 2026.
- Largest single sale: $131K (4,986 shares) of Dyne Therapeutics, Inc. on Aug 13, 2026. Filing
- Last sale before this period: Sep 5, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | CEO & President, Director | Mar 27, 2024 | Sep 8, 2026 |
| Biogen (BIIB) | Former EVP Pharmaceutical Oper & Tech | Aug 10, 2010 | Apr 5, 2016 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 8, 2026, Dyne Therapeutics, Inc.: sold 5,658 shares for $107K, under a disclosed plan. 1 filing: 1
- Aug 13, 2026, Dyne Therapeutics, Inc.: sold 4,986 shares for $131K, under a disclosed plan. 1 filing: 1
- Jun 16, 2026, Dyne Therapeutics, Inc.: sold 2,683 shares for $49K, under a disclosed plan. 1 filing: 1
- May 13, 2026, Dyne Therapeutics, Inc.: sold 3,311 shares for $61K, under a disclosed plan. 1 filing: 1
- Mar 5, 2026, Dyne Therapeutics, Inc.: sold 2,732 shares for $41K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.